Special Drug Use-Results Survey for IMBRUVICA Capsules 140 mg
Latest Information Update: 27 Nov 2019
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 06 Jun 2016 Status changed from not yet recruiting to recruiting.
- 31 May 2016 New trial record